These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 26997423

  • 1. Microencapsulation of rifampicin for the prevention of endophthalmitis: In vitro release studies and antibacterial assessment.
    Lee MY, Bourgeois S, Almouazen E, Pelletier J, Renaud F, Fessi H, Kodjikian L.
    Int J Pharm; 2016 May 30; 505(1-2):262-70. PubMed ID: 26997423
    [Abstract] [Full Text] [Related]

  • 2. Biodegradable rifampicin-releasing coating of surgical meshes for the prevention of bacterial infections.
    Reinbold J, Hierlemann T, Urich L, Uhde AK, Müller I, Weindl T, Vogel U, Schlensak C, Wendel HP, Krajewski S.
    Drug Des Devel Ther; 2017 May 30; 11():2753-2762. PubMed ID: 29075100
    [Abstract] [Full Text] [Related]

  • 3. In vitro efficacy of newly designed vancomycin-based microparticles.
    Hachicha W, Fessi H, Casoli-Bergeron E, Lee MY, Jaafar C, Clayer-Montembault A, Burillon C, Freney J, Kodjikian L.
    J Cataract Refract Surg; 2007 Apr 30; 33(4):702-8. PubMed ID: 17397747
    [Abstract] [Full Text] [Related]

  • 4. PLGA Implants containing vancomycin and dexamethasone: development, characterization and bactericidal effects.
    Resende AFC, Pereira AF, Moreira TP, Patrício PSO, Fialho SL, Cunha GMF, Silva-Cunha A, Magalhães JT, Silva GR.
    Pharmazie; 2016 Aug 01; 71(8):439-446. PubMed ID: 29442030
    [Abstract] [Full Text] [Related]

  • 5. In vitro drug release behavior, mechanism and antimicrobial activity of rifampicin loaded low molecular weight PLGA-PEG-PLGA triblock copolymeric nanospheres.
    Gajendiran M, Divakar S, Raaman N, Balasubramanian S.
    Curr Drug Deliv; 2013 Dec 01; 10(6):722-31. PubMed ID: 23701139
    [Abstract] [Full Text] [Related]

  • 6. A mesoporous silicon/poly-(DL-lactic-co-glycolic) acid microsphere for long time anti-tuberculosis drug delivery.
    Xu W, Wei X, Wei K, Cao X, Zhong S.
    Int J Pharm; 2014 Dec 10; 476(1-2):116-23. PubMed ID: 25271077
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Poly(lactic-co-glycolic) Acid-Lipid Hybrid Microparticles Enhance the Intracellular Uptake and Antibacterial Activity of Rifampicin.
    Maghrebi S, Joyce P, Jambhrunkar M, Thomas N, Prestidge CA.
    ACS Appl Mater Interfaces; 2020 Feb 19; 12(7):8030-8039. PubMed ID: 32013379
    [Abstract] [Full Text] [Related]

  • 9. Preparation of rifampicin-loaded PLGA microspheres for lung delivery as aerosol by premix membrane homogenization.
    Doan TV, Olivier JC.
    Int J Pharm; 2009 Dec 01; 382(1-2):61-6. PubMed ID: 19682562
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Fabrication of a new composite scaffold material for delivering rifampicin and its sustained drug release in rats].
    Ma XM, Lin Z, Zhang JW, Sang CH, Qu DB, Jiang JM.
    Nan Fang Yi Ke Da Xue Xue Bao; 2016 Mar 01; 36(3):309-15. PubMed ID: 27063154
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Formulation and in vitro characterization of inhalable rifampicin-loaded PLGA microspheres for sustained lung delivery.
    Doan TV, Couet W, Olivier JC.
    Int J Pharm; 2011 Jul 29; 414(1-2):112-7. PubMed ID: 21596123
    [Abstract] [Full Text] [Related]

  • 16. S-Nitrosoglutathione loaded poly(lactic-co-glycolic acid) microparticles for prolonged nitric oxide release and enhanced healing of methicillin-resistant Staphylococcus aureus-infected wounds.
    Hlaing SP, Kim J, Lee J, Hasan N, Cao J, Naeem M, Lee EH, Shin JH, Jung Y, Lee BL, Jhun BH, Yoo JW.
    Eur J Pharm Biopharm; 2018 Nov 29; 132():94-102. PubMed ID: 30223029
    [Abstract] [Full Text] [Related]

  • 17. PLGA-based drug delivery systems: importance of the type of drug and device geometry.
    Klose D, Siepmann F, Elkharraz K, Siepmann J.
    Int J Pharm; 2008 Apr 16; 354(1-2):95-103. PubMed ID: 18055140
    [Abstract] [Full Text] [Related]

  • 18. Development of Recombinant Human Growth Hormone (rhGH) sustained-release microspheres by a low temperature aqueous phase/aqueous phase emulsion method.
    Kang J, Wu F, Cai Y, Xu M, He M, Yuan W.
    Eur J Pharm Sci; 2014 Oct 01; 62():141-7. PubMed ID: 24907681
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.